Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Investigator and Participant Blinded, Single Ascending ... और पढ़ें
Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Double-Blind, Active-Control, Multicenter Phase 3 Trial of Casdatifan and Cabozantin... और पढ़ें
Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combin... और पढ़ें
Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'Complementary Herbal Approach to Rheumatoid Management Study (CHARMS)'. The following are the othe... और पढ़ें
Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the po... और पढ़ें
U.S., Oct. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07893444) titled 'BRIGHT-Child TB: Short-Course Treatment for Non-Severe Pulmonary Tuberculosis in Children' ... और पढ़ें
Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the po... और पढ़ें
Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507... और पढ़ें
Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'ROSETTA HCC-206: An Open-Label, Multi-Center, Randomized Phase 1/2 Study of Pumitamig Alone or In ... और पढ़ें
Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'Phase II Open-label Study Evaluating Ivonescimab in PD-1 Resistant Recurrent or Metastatic Nasopha... और पढ़ें